Will the Creightons share price continue to rise?
Consumer goods firm Creightons (LSE: CRL) had a strong 2020. The firm  which makes skin, hair, and beauty products  saw its pre-tax profits rise 64% during the six months to 30 September. Creightons share price has risen by over 55% since June 2020. This small-cap has a market-cap of just 57m and may be under the radar for many private investors. However, its been in business since 1954 and has delivered steady growth in recent years  sales have doubled since 2016. I think there could be more to come. 5G is here  and shares of this sleeping giant could be a great way for you to potentially profit! Creightons sells under a range of brands. The firms products are typically small, repeat purchases, such as shampoo and moisturisers. In some ways, this business reminds me a little of FTSE 100 giant Unilever, whose beauty and personal care business sells similar products. By backing the smaller company over the last five years, Creightons shareholders have seen an 850% share price gain and received a few dividends. By contrast, Unilever (which I hold) has seen its share price rise only 35%, plus (bigger) dividends. Unilevers brands are much larger and better known. Its product range is more diverse, including food, drink and cleaning products as well. But the larger company is also more mature  I cant see Unilever matching Creightons recent growth. The big question for me is whether Creightons can maintain its recent run of growth. The companys annual sales have risen from 21m in 2016 to 56m over the 12 months to 30 September 2020. Pre-tax profit has risen from 0.6m to 4.7m over the same period. Thats an impressive record, in my view. But one concern I have is that last years strong results were boosted by pandemic demand for hygiene products, such as hand sanitisers. In its half-year results, the company admitted that the main driver of sales growth during the period was increased sales of hygiene products, sanitising gels and handwashes. The biggest buyers of these products were the NHS and major UK retailers. Id imagine demand for these products could ease over the coming year. Sales of the groups branded products were said to have continued to grow last year, but the company didnt provide numbers. In my view, theres quite a lot to like about Creightons. My analysis suggests the company has a strong balance sheet, with minimal debt. Profit margins have improved in recent years and Creightons own brands appear to be gaining strength. On the other hand, I can see some risk that sales growth might slow over the next 12-18 months, as demand linked to the pandemic eases. Creightons shares are currently trading on about 15 times earnings from the last 12 months. The company doesnt appear to have any broker coverage, so I cant find any forecasts for this year. However, my research suggests the stocks current valuation is higher than its historic average, suggesting it may not rise further in the short term. I think Creightons share price is probably up with events. Id need to do more research before deciding whether to buy this stock at current levels. But I can see this business as a possible long-term investment for me with a rising share price further down the line. If I already owned the shares, Id be happy to continue holding.